✦ LIBER ✦

Efficacy and Safety of the Vasopressin V1A/V2-Receptor Antagonist Conivaptan in Acute Decompensated Heart Failure: A Dose-Ranging Pilot Study

✍ Scribed by Steven R. Goldsmith; Uri Elkayam; W. Herbert Haught; Abhijit Barve; Weizhong He

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Conivaptan in Acu

✍ Steven R. Goldsmith 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Evaluating the efficacy and safety of th

✍ Steven R. Goldsmith; Joseph G. Bisaha; Neila Smith 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Acute hemodynamic effects of conivaptan,

✍ J.E. Udelson; W.B. Smith; G.H. Hendrix 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Cardiovascular and renal effects of coni

✍ Takeyuki Yatsu; Yuichi Tomura; Atsuo Tahara; Koh-ichi Wada; Toshiyuki Kusayama; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 466 KB

Pharmacokinetics of conivaptan hydrochlo

✍ Zhongping Lily Mao; Dennis Stalker; James Keirns 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 866 KB

Effects of Lixivaptan, a Novel Vasopress

✍ William Abraham; Steven Goldsmith; Stephen Gottlieb 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 149 KB